Amicogen, Inc.
KOSDAQ 092040.KQ
Amicogen, Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 0.24%
-
Amicogen, Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was -19.20%, a -340.77% change year over year.
-
Amicogen, Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 7.98%, a -60.05% change year over year.
-
Amicogen, Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 19.97%, a 2,725.10% change year over year.
-
Amicogen, Inc. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 0.71%, a -43.52% change year over year.
| Date | Return on Capital Employed (ROCE) | Interest Coverage Ratio | Debt to Equity Ratio | Return on Common Equity |
|---|
| CEO | Piao Zhe |
| IPO Date | Sept. 12, 2013 |
| Location | South Korea |
| Headquarters | 64, Dongbu-ro |
| Employees | 225 |
| Sector | Health Care |
| Industries | |
Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company offers specialty enzymes, including CX, SP, etc. for pharmaceutical, food, chemical, and energy industries. It also provides new bio-ingredients, such as N-acetylglucosamine for skin moisturizing and joint health; pinitol/D-chiro-inositol; collagen peptide and collagen tripeptide for skin and health; chitoslim and chitosan oligosaccharides; and lactic acid bacteria, as well as fucoxanthin, curezyme, food enzyme, and bamboo salt. In addition, the company offers K-nutra, a healthcare brand; and KeyClean, a disinfectant brand. Further, it provides protein purification resins. The company was founded in 2000 and is headquartered in Jinju-si, South Korea.
Past 5 years
USD 209.72
USD 36.96
USD 30.55
StockViz Staff
January 15, 2025
Any question? Send us an email